Advisory Alpha LLC Buys 439 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisory Alpha LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.7% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,147 shares of the medical equipment provider’s stock after buying an additional 439 shares during the period. Advisory Alpha LLC’s holdings in Intuitive Surgical were worth $1,121,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. State Street Corp raised its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC raised its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC lifted its stake in Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after purchasing an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. increased its position in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on ISRG. Leerink Partners boosted their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Trading Up 1.0 %

NASDAQ ISRG opened at $610.45 on Thursday. The stock’s fifty day moving average price is $543.14 and its 200-day moving average price is $501.89. The stock has a market cap of $217.43 billion, a P/E ratio of 98.14, a P/E/G ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $614.72.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 43,487 shares of company stock valued at $22,590,975. 0.80% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.